We are live on ! Find out more
ATRA icon

Atara Biotherapeutics
ATRA

154 hedge funds and large institutions have $376M invested in Atara Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 28 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 28

100% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 20

15% more funds holding

Funds holding: 134 → 154 (+20)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.06% less ownership

Funds ownership: 4.27% → 4.22% (-0.06%)

52% less capital invested

Capital invested by funds: $776M → $376M (-$400M)

67% less call options, than puts

Call options by funds: $114K | Put options by funds: $342K

Holders
154
Holders Change
+20
Holders Change %
+14.93%
% of All Funds
2.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
63
Reduced
28
Closed
20
Calls
$114K
Puts
$342K
Net Calls
-$228K
Net Calls Change
-$2.14M

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$13.5M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$9.22M
3
State Street
State Street
Massachusetts
+$8.43M
4
Goldman Sachs
Goldman Sachs
New York
+$8.18M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.29M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$25.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.3M
3
EC
Eminence Capital
New York
-$10.3M
4
AG
Artal Group
Luxembourg
-$7.79M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$4.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$2.43M +$1.56M +13,890 +118%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$2.33M -$2.37M -21,119 -46%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$2.27M -$23.7K -211 -0.9%
PHAM
29
Pacific Heights Asset Management
California
$1.98M – – –
N
30
Nuveen
North Carolina
$1.98M +$4.83K +43 +0.2%
AQR Capital Management
31
AQR Capital Management
Connecticut
$1.93M +$2.29M +20,407 New
Bank of America
32
Bank of America
North Carolina
$1.83M +$616K +5,487 +40%
SCA
33
STALEY CAPITAL ADVISERS
Pennsylvania
$1.7M +$112K +1,000 +6%
PA
34
Pinnacle Associates
New York
$1.51M -$136K -1,211 -7%
Walleye Capital
35
Walleye Capital
New York
$1.42M +$1.69M +15,040 New
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$1.34M +$1.6M +14,213 New
Barclays
37
Barclays
United Kingdom
$1.31M +$1.46M +12,961 +1,500%
Renaissance Technologies
38
Renaissance Technologies
New York
$1.27M +$498K +4,436 +49%
AIMCA
39
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.2M – – –
Ohio Public Employees Retirement System (OPERS)
40
Ohio Public Employees Retirement System (OPERS)
Ohio
$966K +$522K +4,645 +83%
HWAM
41
Hennion & Walsh Asset Management
New Jersey
$931K +$80.2K +714 +8%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$854K +$750K +6,678 +284%
CS
43
Candriam SCA
Luxembourg
$849K +$1.01M +8,984 New
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$834K +$596K +5,304 +151%
Fidelity Investments
45
Fidelity Investments
Massachusetts
$817K -$25.3M -225,197 -96%
Squarepoint
46
Squarepoint
New York
$771K +$916K +8,156 New
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$749K +$770K +6,856 +638%
CANY
48
Caxton Associates (New York)
New York
$745K +$829K +7,383 +1,483%
Swiss National Bank
49
Swiss National Bank
Switzerland
$705K – – –
RJA
50
Raymond James & Associates
Florida
$697K +$535K +4,765 +183%
1
2
3 4 5

ATRA Hedge Fund Activity: Q3 2022 in Review

154 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Atara Biotherapeutics (ATRA) for Q3 2022, worth a combined $376M — down 52% from $776M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new ATRA positions and 20 closed out — a net gain of 20 holders — while 63 added to existing stakes and 28 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $13.5M. The largest seller was Fidelity Investments, cutting an estimated $25.3M.

  • 154 institutional investors held Atara Biotherapeutics (ATRA) as of Q3 2022, up from 134 in Q2 2022.
  • Funds reported $376M of Atara Biotherapeutics stock for Q3 2022, down 52% quarter-over-quarter.
  • 40 funds opened new Atara Biotherapeutics positions in Q3 2022 and 20 closed out, a net change of +20 holders.
  • The largest Atara Biotherapeutics buyer in Q3 2022 was Wasatch Advisors, an estimated $13.5M added.
  • The largest Atara Biotherapeutics seller in Q3 2022 was Fidelity Investments, an estimated $25.3M sold.

Based on aggregated 13F filings for Q3 2022.